ST
Stoke Therapeutics Inc
🇺🇸XNAS.STOKUnited StatesHealthcare
$28.19USDup +0.04 (+0.14%)OpenDelayed4:15 PM
Price$28.19+0.04 (+0.14%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US86150R1077
- CUSIP
- 86150R107
Company
- Employees
- 170
- Headquarters
- Bedford, United States
- CEO
- Mr. Ian F. Smith A.C.A., C.P.A.
Market
- Shares outstanding
- 64.5M
- Market cap
- $1.82B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $1.82B
- EPS LTM
- -$3.15
- P/E LTM
- -10.38
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $27.59M-86.2%down year on year
- Net income
- -$207.9M-496.12%down year on year
- Gross margin
- 84.67%-13.44%down year on year
- Free cash flow
- -$180.68M-395.49%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.